OmniComm Systems, Inc. (OTC: OMCM.OB), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced that its Electronic Data Capture (EDC) suite, TrialMaster®, has been chosen by three West Coast pharmaceutical companies to support multiple clinical trial programs. All of these companies are new to OmniComm and will initially be utilizing TrialMaster to manage the data collection in four clinical trials, including two phase I and two phase II studies.
"We are honored by the number of new customers that have chosen OmniComm to partner with for their clinical research needs," commented Stephen Johnson, OmniComm's President & COO. "This makes 11 new customers for us in the first half of 2012 alone. The word is getting out…better products, better service, better value."
OmniComm is coming off its best year ever in 2011, and continues to show record growth in 2012. OmniComm attributes its success to innovative new products and features, such as TrialMaster's automated SDTM export utility and Dynamic Monitoring module. "TrialMaster has a very flexible architecture that allows us to innovate rapidly," said Keith Howells, SVP of Development. "We are delighted that companies researching the next generation of medicines are seeing the benefits of providing leading edge tools to their staff and investigative sites. Their productivity is our success".
About OmniComm
OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm Systems, Inc. has U.S. headquarters in Fort Lauderdale, FL and European headquarters in Bonn, Germany, with satellite offices in New Jersey and the United Kingdom, as well as sales offices throughout the U.S. and Europe.
Safe Harbor Disclaimer
Statements made by OmniComm included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.